These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33235501)

  • 1. Up-Regulation of miR-26a-5p Inhibits E2F7 to Regulate the Progression of Renal Carcinoma Cells.
    Cheng C; Guo L; Ma Y; Wang Z; Fan X; Shan Z
    Cancer Manag Res; 2020; 12():11723-11733. PubMed ID: 33235501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DLEU7-AS1 promotes renal cell cancer by silencing the miR-26a-5p/coronin-3 axis.
    Wang XJ; Chen L; Xu R; Li S; Luo GC
    Clin Kidney J; 2022 Aug; 15(8):1542-1552. PubMed ID: 35892027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-26a-5p inhibits proliferation, invasion and metastasis by repressing the expression of Wnt5a in papillary thyroid carcinoma.
    Shi D; Wang H; Ding M; Yang M; Li C; Yang W; Chen L
    Onco Targets Ther; 2019; 12():6605-6616. PubMed ID: 31496749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
    Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
    EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-424-5p regulates cell cycle and inhibits proliferation of hepatocellular carcinoma cells by targeting E2F7.
    Zhao Y; Zhu C; Chang Q; Peng P; Yang J; Liu C; Liu Y; Chen X; Liu Y; Cheng R; Wu Y; Wu X; Hu L; Yin J
    PLoS One; 2020; 15(11):e0242179. PubMed ID: 33201900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SNHG7 Contributes to the Progression of Non-Small-Cell Lung Cancer via the SNHG7/miR-181a-5p/E2F7 Axis.
    Wang L; Zhang L; Wang L
    Cancer Manag Res; 2020; 12():3211-3222. PubMed ID: 32440218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA HCG11 accelerates the progression of hepatocellular carcinoma via miR-26a-5p/ATG12 axis.
    Li ML; Zhang Y; Ma LT
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10708-10720. PubMed ID: 31858580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircRNA SCARB1 Promotes Renal Cell Carcinoma Progression Via Mir- 510-5p/SDC3 Axis.
    Sun J; Pan S; Cui H; Li H
    Curr Cancer Drug Targets; 2020; 20(6):461-470. PubMed ID: 32271695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA SNHG4 promotes renal cell carcinoma tumorigenesis and invasion by acting as ceRNA to sponge miR-204-5p and upregulate RUNX2.
    Wu J; Liu T; Sun L; Zhang S; Dong G
    Cancer Cell Int; 2020; 20():514. PubMed ID: 33088220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA 00312 Attenuates Cell Proliferation and Invasion and Promotes Apoptosis in Renal Cell Carcinoma via miR-34a-5p/ASS1 Axis.
    Zeng J; Li Y; Wang Y; Xie G; Feng Q; Yang Y; Feng J
    Oxid Med Cell Longev; 2020; 2020():5737289. PubMed ID: 32308805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-26a-5p suppresses tumor metastasis by regulating EMT and is associated with prognosis in HCC.
    Chang L; Li K; Guo T
    Clin Transl Oncol; 2017 Jun; 19(6):695-703. PubMed ID: 27864783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1.
    Guo K; Zheng S; Xu Y; Xu A; Chen B; Wen Y
    Tumour Biol; 2016 Sep; 37(9):12843-12854. PubMed ID: 27449037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1).
    Li Y; Quan J; Chen F; Pan X; Zhuang C; Xiong T; Zhuang C; Li J; Huang X; Ye J; Zhang F; Zhang Z; Gui Y
    Biomed Pharmacother; 2019 Mar; 111():517-526. PubMed ID: 30597305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC00657/miR-26a-5p/CKS2 ceRNA network promotes the growth of esophageal cancer cells via the MDM2/p53/Bcl2/Bax pathway.
    Zhang XM; Wang J; Liu ZL; Liu H; Cheng YF; Wang T
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32426838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-26a-5p Inhibit Gastric Cancer Cell Proliferation and Invasion Through Mediated Wnt5a.
    Li Y; Wang P; Wu LL; Yan J; Pang XY; Liu SJ
    Onco Targets Ther; 2020; 13():2537-2550. PubMed ID: 32273724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual inhibition of RNAi therapeutic miR-26a-5p targeting cMet and immunotherapy against EGFR in endometrial cancer treatment.
    Liu Y; Cai Y; Chang Y
    Ann Transl Med; 2021 Jan; 9(1):5. PubMed ID: 33553298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NEK6 Promotes the Progression of Osteosarcoma Through Activating STAT3 Signaling Pathway by Down-Regulation of miR-26a-5p.
    Zhu M; Sun Y; Xue H; Wu G; Wang Z; Shi J; Ma J; Gu B; Yan X
    Int J Gen Med; 2023; 16():2831-2848. PubMed ID: 37426517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA DLEU2 promotes the progression of esophageal cancer through miR-30e-5p/E2F7 axis.
    Lu T; Wang R; Cai H; Cui Y
    Biomed Pharmacother; 2020 Mar; 123():109650. PubMed ID: 31884338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA SNHG5 promotes growth and invasion in melanoma by regulating the miR-26a-5p/TRPC3 pathway.
    Gao J; Zeng K; Liu Y; Gao L; Liu L
    Onco Targets Ther; 2019; 12():169-179. PubMed ID: 30636880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of miR-18a-5p as an oncogene and prognostic biomarker in RCC.
    Zhou L; Li Z; Pan X; Lai Y; Quan J; Zhao L; Xu J; Xu W; Guan X; Li H; Yang S; Gui Y; Lai Y
    Am J Transl Res; 2018; 10(6):1874-1886. PubMed ID: 30018727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.